36th week of 2011 patent applcation highlights part 41 |
Patent application number | Title | Published |
20110218217 | PIPERIDYLPROPIONAMIDE DERIVATIVES USEFUL FOR THE TREATMENT OF CNS DISORDERS INCLUDING DEPRESSION AND PANIC DISORDER - This invention relates to novel piperidine-4-propionamide derivatives useful as monoamine neurotransmitter re-uptake inhibitors. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention. | 2011-09-08 |
20110218218 | Formulations Of Indanylamines And The Use Thereof As Local Anesthetics And As Medication For Chronic Pain - Internal-dermal formulations of RS—, S—, or R-2-[2-(N-phenyl-N-2-indanyl)aminoethyl]piperidine causing intradermal accumulation of said piperidine and intended for the treatment of neuropathic pain are provided, as well as a method of inducing the relief of pain using the compounds. | 2011-09-08 |
20110218219 | SUBSTITUTED SULPHONAMIDO PHENOXYBENZAMIDES - The present invention relates to substituted sulphonamido phenoxybenzamide compounds of general formula (I): | 2011-09-08 |
20110218220 | RATIONALLY IMPROVED ISONIAZID AND ETHIONAMIDE DERIVATIVES AND ACTIVITY THROUGH SELECTIVE ISOTOPIC SUBSTITUTION - The present invention relates to the use of isotopically labeled derivatives of isoniazid, ethionamide and related compounds as effective therapy for the treatment of mycobacterial diseases, including | 2011-09-08 |
20110218221 | NOVEL HISTONE DEACETYLASE INHIBITORS, PROCESS FOR PREPARATION AND USES THEREOF - The present invention relates to compounds represented by formula (I) or composition comprising at least one of such compounds, which are inhibitors of histone deacetylase. The detailed description of these compounds is disclosed in the Description. These compounds and the composition comprising the same may be useful as medicaments for the treatment of proliferative disorders as well as other diseases involving, relating to or associated with enzymes having histone deacetylase (HDAC) activities. | 2011-09-08 |
20110218222 | NEURORESTORATION WITH R(+) PRAMIPEXOLE - Formulations and methods of use thereof for restoring neuronal, muscular (cardiac and striated) and/or retinal tissue function in children and adults afflicted with chronic neurodegenerative diseases, such as neurodegenerative movement disorders and ataxias, seizure disorders, motor neuron diseases, and inflammatory demyelinating disorders, are described herein. Examples of disorders include Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). The method involves administering a pharmaceutical composition containing an effective amount of a tetrahydrobenzathiazole, preferably a formulation consisting substantially of the R(+) enantiomer of pramipexole. R(+) pramipexole is generally administered in doses ranging from 0.1-300 mg/kg/daily, preferably 0.5-50 mg/kg/daily, and most preferably 1-10 mg/kg/daily for oral administration. Daily total doses administered orally are typically between 10 mg and 500 mg. Alternatively, R(+) pramipexole can be administered parenterally to humans with acute brain injury in single doses between 10 mg and 100 mg, and/or by continuous intravenous infusions between 10 mg/day and 500 mg/day. | 2011-09-08 |
20110218223 | TOPICAL VASOCONSTRICTOR PREPARATIONS AND METHODS FOR PROTECTING CELLS DURING CANCER CHEMOTHERAPY AND RADIOTHERAPY - Vasoconstrictors are administered topically to provide protection against the adverse effects, e.g., alopecia, mucositis or dermatitis, induced by chemotherapy or radiotherapy. Appropriate dosages and formulations of topical vasoconstrictors are provided. Methods for the use of such compositions are also provided. | 2011-09-08 |
20110218224 | CRYSTALLINE ALKOXYIMIDAZOL-1-YLMETHYL BIPHENYL CARBOXYLIC ACID AND METHODS FOR PREPARING THEREOF - The invention provides a micronized 4′-{2-ethoxy-4-ethyl-5-[((S)-2-mercapto-4-methylpentanoylamino)methyl]imidazol-1-ylmethyl}-3′-fluorobiphenyl-2-carboxylic acid having improved stability. The invention also provides pharmaceutical compositions comprising the stable micronized compound, processes for preparing the stable micronized compound, and methods of using the stable micronized compound to treat diseases such as hypertension. | 2011-09-08 |
20110218225 | NON-STEROIDAL LIGANDS FOR THE GLUCOCORTICOID RECEPTOR, COMPOSITIONS AND USES THEREOF - The invention provides non-steroidal ligands for the glucocorticoid receptor, methods for making non-steroidal ligands of the glucocorticoid receptor, compositions of non-steroidal ligands of the glucocorticoid receptor and methods of using non-steroidal ligands and compositions of non-steroidal ligands of the glucocorticoid receptor for treating or preventing diseases (e.g., obesity, diabetes, depression, neurodegeneration or an inflammatory disease) associated with glucocorticoid binding to the glucocorticoid receptor. | 2011-09-08 |
20110218226 | ANTI-VIRULENCE COMPOSITIONS AND METHODS - A method of reducing the virulence of a bacterium that expresses accessory gene regulator A (AgrA) includes administering to the bacterium an amount of AgrA antagonist effective to inhibit the synthesis of one or more virulence factors by the bacterium. | 2011-09-08 |
20110218227 | HYDRATE CRYSTALS - New (2R,4R) monatin monosodium salt hydrate crystals characterized by having specific characteristic X-ray diffraction peaks provide general-purpose, stable, and safe monatin sodium salt crystals incorporating no organic solvent. These crystal may be prepared by a method that requires no organic solvent in the crystallization, separation, and drying steps. These crystal are useful as sweeteners and for the preparation of orally consumed products, such as foods, beverages, pharmaceutical products, topical pharmaceutical products, and feeds containing general-purpose, stable, and safe monatin sodium salt crystals. | 2011-09-08 |
20110218228 | CRYSTALLINE SODIUM ATORVASTATIN - Crystalline sodium atorvastatin, compositions containing the same and methods for the production thereof. | 2011-09-08 |
20110218229 | SIRT1 Modulation of Adipogenesis and Adipose Function - SIRT1 regulates the physiology of cells of the adipocyte lineage. Modulators of SIRT1 activity can be used to ameliorate, treat, or prevent diseases and disorders associated with adipose physiology, e.g., obesity, an obesity-related disease, or a fat-related metabolic disorder. | 2011-09-08 |
20110218230 | NATRIURETIC PEPTIDE RELATED FRAGMENT IN CARDIOVASCULAR DISEASE - This disclosure provides an intracellular fragment of natriuretic peptide receptor A (NPRA), referred to herein as soluble natriuretic peptide receptor-related fragment (sNRF). It is shown herein that sNRF causes NP resistance. Based on these observations, methods of treating a cardiovascular disorder by inhibiting the activity of sNRF are disclosed. Assays are provided that use sNRF to screen agents for their ability to increase the biological activity of an NPR, for example agents that increase the sensitivity of NPR for NPs (such as atrial natriuretic peptide, ANP), or that decrease growth factor deleterious effects, or combinations thereof. Also provided are agents identified using the disclosed assays, and methods of using the agents, for example to treat or diagnose a cardiovascular disorder, such as heart failure. | 2011-09-08 |
20110218231 | Combination of Immuno Gene Therapy and Chemotherapy for Treatment of Cancer and Hyperproliferative Diseases - Pharmaceutical compositions comprising a nucleic acid, a gene delivery polymer, and at least one adjunctive chemotherapeutic drug for the treatment of mammalian cancer or hyperproliferative disorders and methods of using thereof for the treatment of mammalian cancer or hyperproliferative disorders by intratumoral, intraperitoneal or systemic injection. | 2011-09-08 |
20110218232 | Inhibitors of MRP4 and Agents Stimulating MRP4 Activity for the Treatment of Cardiac Disorders - The invention relates to inhibitors of Multi drug Resistant Protein 4 (MRP4) for the treatment and/or the prevention of cardiac disorders, such as acute or chronic heart failure and cardiogenic shock. The invention also relates to agents stimulating MRP4 activity for the treatment and/or the prevention of cardiac hypertrophy. | 2011-09-08 |
20110218233 | TREATMENT OF SCLERODERMA - The present invention provides a method of treating scleroderma. The method consists in the upregulation of miR-29 by administration of miR-29 or a miR-29 upregulator which elevates circulating and/or intracellular concentrations of miR-29. The invention likewise relates to the use of miR-29 for such a treatment, and the use of miR-29 for the manufacture of a medicament for the treatment of scleroderma. | 2011-09-08 |
20110218234 | GENE VECTOR FOR INDUCING TRANSGENE-SPECIFIC IMMUNE TOLERANCE - A gene vector adapted for transient expression of a transgene in a peripheral organ cell comprising a regulatory sequence operably linked to a transgene wherein the regulatory sequence prevents or reduces expression of said transgene in hematopoietic lineage cells. | 2011-09-08 |
20110218235 | COMPOUND AND COMPOSITION AND THEIR USES THEREOF - A compound, composition, method of synthesizing and using the compound of formula 1 are disclosed. The compound of formula I also comprises of salts, polymorphs, solvates, and hydrates thereof. The compound may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for peroral, topical, transmucosal, inhalation, targeted delivery and sustained release formulations. Such compositions may be used to treat hepatic and genetic disorders related to copper overload. | 2011-09-08 |
20110218236 | COMPOUND AND COMPOSITION AND THEIR USES THEREOF - A compound, composition and method of making and using a compound of formula 1 are disclosed. The compound of formula I also comprises of salts, polymorphs, solvates, mesylates, hydrochloric salt, solvates and hydrates thereof. The compound may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for peroral, topical, transmucosal, inhalation, targeted delivery and sustained release formulations. Such compositions may be used to treat metal accumulation in blood, organs and due to genetic complications. | 2011-09-08 |
20110218237 | COMPOUND AND COMPOSITION AND THEIR USES THEREOF - A compound, composition and method of making and using a compound of formula 1 are disclosed. The compound of formula I also comprises of salts, polymorphs, solvates, mesylates, hydrochloric salt, solvates and hydrates thereof. The compound may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for peroral, topical, transmucosal, inhalation, targeted delivery and sustained release formulations. Such compositions may be used to treat metal accumulation in blood, organs and due to genetic complications. | 2011-09-08 |
20110218238 | COMPOUNDS, COMPOSITIONS, FORMULATIONS AND THEIR USES THEREOF - A compound, composition, method of synthesizing and using the compound of formula 1 are disclosed. The compound of formula I also comprises of salts, polymorphs, solvates, and hydrates thereof. The compound may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for peroral, topical, transmucosal, inhalation, targeted delivery and sustained release formulations. Such compositions may be used to treat hepatic and genetic disorders related to copper overload. Multiple other compounds may be added with the instant claimed compounds and may be delivered as a pharmaceutical dose suitable for treating Wilson's disease. | 2011-09-08 |
20110218239 | Use of 5,6-Dimethylxanthenone-4-Acetic Acid as an Antiviral Agent - The invention relates to the areas of therapeutics, pharmaceuticals, drug discovery, and immunotherapy. More specifically, the present invention relates to methods of stimulating the immune system through the administration of flavone acetic acid [FAA] analogues, and in particular, the flavone acetic acid analogue, 5,6-dimethylxanthenone-4-acetic acid (DMXAA) so as to comprise an antimicrobial therapeutic agent for the treatment of viral infections of DNA and RNA viruses in humans and non-human animals. The invention is especially suitable for use in a process of treating and preventing infection by, for example, rhinoviruses, enteroviruses, and influenza viruses. | 2011-09-08 |
20110218240 | NOVEL COMPOUND WITH SPIRO CHIRAL CARBON BACKBONE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME - Provided are a novel compound with a spiro chiral carbon backbone, a stereoisomer thereof, an enantiomer thereof, an in vivo hydrolysable precursor thereof, or a pharmaceutically acceptable salt thereof. The novel compound with the spiro chiral carbon backbone has excellent osteoblast differentiation activity, mast cell inhibitory activity, and fatty acid synthesis inhibitory activity in the liver. Therefore, the novel compound can be expected to play an innovative role in treatment of osteoporosis, fatty liver, and obesity. | 2011-09-08 |
20110218241 | ANTIVIRAL EPICATECHINS, EPICATECHIN OLIGOMERS, OR THIOLATED EPICATECHINS FROM THEOBROMA CACAO FOR TREATMENT OF GENITAL WARTS - Epicatechins, Epicatechin Oligomers, or Thiolated Epicatechins are applied (A) directly to a genital wart in the form of a cream, ointment, paste or solution, (B) directly to the genital wart wherein such cream, ointment, paste or solution contains as an additional active ingredient a skin permeabilizing agent, (C) following electrosurgical resection or removal of the genital wart in such form of a cream, ointment, paste or solution, (D) following chemical resection or extirpation of the genital wart in such form, (E) following surgical resection or removal of the genital wart in such form, wherein said Epicatechins, Epicatechin Oligomers, or Thiolated Epicatechins both provide antiviral activity against multiple strains of human papilloma virus (HPV) and promote healing following resection polymers contained in a vehicle. Disclosed are the compositions, therapeutical kits containing such composition, methods of treatment using such composition, and methods of enhancing the stability of such composition. | 2011-09-08 |
20110218242 | Polyunsaturated Fatty Acids for Treatment of Dementia and Pre-Dementia-Related Conditions - Disclosed are compositions and methods for treating or preventing dementia and pre-dementia-related conditions and/or symptoms or characteristics of such conditions. | 2011-09-08 |
20110218243 | COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE - In various embodiments, the present invention provides pharmaceutical compositions comprising fatty acids and methods for treating subjects using same. | 2011-09-08 |
20110218244 | CREATINE -ALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE - Disclosed are creatine β-alaninate, compositions and formulations containing same, and methods of use therefor. | 2011-09-08 |
20110218245 | USE OF COMPOUNDS TO INHIBIT 5A-REDUCTASE ENZYME ACTIVITY, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM - The object of the present invention is the use of compounds designed to inhibit the activity of the enzyme 5α-reductase. This is a novel use of compounds of general formula (I): | 2011-09-08 |
20110218246 | METHODS OF TREATING NON-NOCICEPTIVE PAIN STATES WITH GASTRIC RETENTIVE GABAPENTIN - Provided is a method of treating a patient suffering from a pain state by administering to the patient a gastric retentive dosage form of gabapentin that is capable of administration in once-daily or twice daily dosing regimens. By reducing the need to administer gabapentin from the thrice-daily administrations characteristic of immediate release gabapentin, the gastric retentive gabapentin dosage forms provided herein have the advantages of improving patient compliance for gabapentin treatment. In addition to the foregoing, the gastric retentive gabapentin dosages forms also exhibit decreased blood plasma concentrations and increased bioavailability throughout the dosing regimen. | 2011-09-08 |
20110218247 | FORMULATIONS OF LOW DOSE DICLOFENAC AND BETA-CYCLODEXTRIN - The present invention is directed to a pharmaceutical composition containing a unit dose of a diclofenac compound effective to induce analgesia; and a beta-cyclodextrin compound; wherein the dose of the diclofenac compound is less than 10 mg. The present invention is also directed to methods of treating a subject in need of analgesia with the pharmaceutical compositions of the invention. | 2011-09-08 |
20110218248 | ORGANIC COMPOUNDS - The present invention relates to salts, polymorphs and hydrates of 2-Amino-2-[2-(4-C | 2011-09-08 |
20110218249 | USE OF HYPERICUM PERFORATUM EXTRACTS IN THE TREATMENT OF NEUROPATHIC PAIN - Disclosed is the use of | 2011-09-08 |
20110218250 | COMPOSITION BASED ON GLYCEROL ETHER/POLYOL MIXTURES - The invention relates to compositions which comprise one or more glycerol ethers together with one or more diol/diols and/or polyol/polyols. As a result, as well as good microbicidal effectiveness, whitening is reduced or avoided, drying-out of the skin is prevented, the moisture content is regulated and the skin is regreased to an adequate extent. | 2011-09-08 |
20110218251 | Products with water clusters - A product has solid stable water clusters including a plurality of water molecules connected with one another by electrical dipole interaction via internal electric field of ions and having a permanent electric dipole moment with an electrical field surrounding the solid stable water clusters. | 2011-09-08 |
20110218252 | Liquid Chromatographic Fraction of Enzymatically Polymerized Flavonoid as an Antioxidant - Disclosed is a separated fraction of a reaction product of an enzymatically catalyzed polymerization of a flavonoid. The separated fraction is highly resistant to oxidation and is useful in numerous applications such as an antioxidant in food products and medical applications. | 2011-09-08 |
20110218253 | IMAGING-BASED IDENTIFICATION OF A NEUROLOGICAL DISEASE OR A NEUROLOGICAL DISORDER - System(s) and method(s) are provided to enable imaging-based identification, detection, evaluation, and mapping of white matter microstructure and hemispheric organization of white matter in a central nervous system (CNS) structure afflicted by a neurological disease or disorder. Various embodiments exploit a set of diffusion tensor metrics to define a classification sub-space and determine a multivariate classifier through training data related to at least two groups of subjects: a first group of subjects afflicted by the neurological disease or neurological disorder, and a second group of subjects typically developing. The set of diffusion tensor metrics can be selected based at least on clinical information related to the neurological disease or neurological disorder and anatomy of CNS structure. Inclusion of tensor skewness asymmetry in such set yields an increase in sensitivity, specificity, accuracy, reliability, and predictive ability of the biological discrimination of subjects with and without a neurological disease or neurological disorder. | 2011-09-08 |
20110218254 | USING FOSSIL FUELS TO INCREASE BIOMASS-BASED FUEL BENEFITS - In the production of fuel such as ethanol from carbonaceous feed material such as biomass, a stream comprising hydrogen and carbon monoxide is added to the raw gas stream derived from the feed material, and the resulting combined stream is converted into fuel and a gaseous byproduct such as by a Fischer-Tropsch reaction. The gaseous byproduct may be utilized in the formation of the aforementioned stream comprising hydrogen and carbon monoxide. | 2011-09-08 |
20110218255 | ARYLENE-FLUORINATED-SULFONIMIDE IONOMERS AND MEMBRANES FOR FUEL CELLS - The preparation of aromatic sulfonimide polymers useful as membranes in electrochemical cells is described. | 2011-09-08 |
20110218256 | PARTIALLY FLUORINATED CYCLIC IONIC POLYMERS AND MEMBRANES - Ionic polymers are made from selected partially fluorinated dienes, in which the repeat units are cycloaliphatic. The polymers are formed into membranes. | 2011-09-08 |
20110218257 | PARTICULATE, EXPANDABLE POLYMER, METHOD FOR PRODUCING PARTICULATE EXPANDABLE POLYMER, AS WELL AS A SPECIAL USE OF THE OBTAINED FOAM MATERIAL - The present invention relates to a particulate, expandable polymer, for example polystyrene (EPS) or polylactic acid (PLA) or a combination thereof, which can be processed to form a foam having a fine cell structure and a low density, and which contains a thermal insulation value-increasing material so as to increase the thermal insulation value thereof The present invention further relates to a method for producing such particulate, expandable polymer, as well as to a foam material based on such a polymer. | 2011-09-08 |
20110218258 | METHOD FOR PRODUCING VISCOELASTIC POLYURETHANE FLEXIBLE FOAMS - The invention relates to a process for producing viscoelastic flexible polyurethane foams by reacting
| 2011-09-08 |
20110218259 | PREPARING POLYURETHANES - The invention relates to a process for preparing polyurethanes, which comprises reacting
| 2011-09-08 |
20110218260 | Mixed Glycol Polyphosphonate Compounds - New highly-effective non-halogen, low VOC, low fogging, and cost-effective oligomeric polyphosphonate flame retardants for flexible polyurethane foams as well as for other flame retardant applications are described. In addition, methods for the preparation and uses of such new highly effective flame retardants are described. Formula (I) | 2011-09-08 |
20110218261 | FOAM-FORMING COMPOSITIONS CONTAINING AZEOTROPIC OR AZEOTROPE-LIKE MIXTURES CONTAINING Z-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE AND THEIR USES IN THE PREPARATION OF POLYISOCYANATE-BASED FOAMS - Foam-forming compositions containing azeotropic or azeotrope-like mixtures containing cis-1,1,1,4,4,4-hexafluoro-2-butene are disclosed. The foam-forming composition contains (a) an azeotropic or azeotrope-like mixture of cis-1,1,1,4,4,4-hexafluoro-2-butene with methyl formate, 1,1,1,3,3-pentafluorobutane, trans-1,2-dichloroethylene, pentane, isopentane, cyclopentane, HFC-245fa, or dimethoxymethane; and (b) an active hydrogen-containing compound having two or more active hydrogens. Also disclosed is a closed-cell polyurethane or polyisocyanurate polymer foam prepared from reaction of an effective amount of the foam-forming composition with a suitable polyisocyanate. Also disclosed is a process for producing a closed-cell polyurethane or polyisocyanurate polymer foam by reacting an effective amount of the foam-forming composition with a suitable polyisocyanate. | 2011-09-08 |
20110218262 | PREPARING RIGID POLYURETHANE FOAMS - The invention relates to a process for preparing rigid polyurethane foams, which comprises reacting
| 2011-09-08 |
20110218263 | POLISHING PAD - A polishing pad generates very few scratches on a surface of a polishing object, and is excellent in planarization property. The polishing pad has a high polishing rate and is excellent in planarization property. The polishing pad grooves become very little clogged with abrasive grains or polishing swarf during polishing and, even when continuously used for a long period of time, the polishing rate is scarcely reduced. | 2011-09-08 |
20110218264 | MODIFIED NATURAL OILS AND PRODUCTS MADE THEREFROM - A modified natural oil made from reacting at least one natural oil or fat comprising at least one ene moiety with at least one of an enophile or dienophile mixture to form at least one modified natural oil, and reacting the at least one modified natural oil which may be used in a variety of processes. | 2011-09-08 |
20110218265 | POLYIMIDE FOAM AND METHOD FOR PRODUCING SAME - Disclosed is a polyimide foam made of an aromatic polyimide composed of a tetracarboxylic acid component, which is composed of 0 to 90% by mole of a 3,3′,4,4′-biphenyltetracarboxylic acid component and 100 to 10% by mole of a 3,3′,4,4′-benzophenone tetracarboxylic acid component and/or a 2,3,3′,4′-biphenyltetracarboxylic acid component, and a diamine component, which is composed of 50 to 97% by mole of m-phenylenediamine and 50 to 3% by mole of 4,4′-methylenedianiline. The polyimide foam can be produced easily, has uniform and fine cells, and has the mechanical properties required for practical use as a foam, such as flexibility that prevents the foam from cracking easily even when deformed and excellent cushioning properties, as well as heat resistance that can resist use at high temperatures. | 2011-09-08 |
20110218266 | PHOTOINITIATOR MIXTURES - Photoinitiators mixture comprising (i) at least one compound selected from the group consisting of alpha-hydroxy ketones, monoacylphosphine oxides, bisacylphosphine oxides, ketosulfones, benzil ketals, benzoin ether, phenylglyoxylates, borates and titanocenes; and (ii) at least one compound of the formula (I) or (I′) R | 2011-09-08 |
20110218267 | SEALANT FOR ONE-DROP FILL PROCESS - A sealant for a one drop fill process is characterized by curing through two steps consisting of photocure using visible light from which 400 nm or shorter wavelengths are cut off and thermal cure and, when in contact with a liquid crystal composition, is less contaminating to the liquid crystal composition with a photo radical initiator, and exhibits high adhesive strength to a substrate. The sealant contains (1) a titanocene photo radical initiator, (2) a photocuring resin, (3) a latent epoxy curing agent and, if necessary, (4) a monomer having at least two glycidyl ether groups per molecule as a thermosetting resin. | 2011-09-08 |
20110218268 | X-ray Opaque Barium-Free Glasses and Uses Thereof - Zirconium-containing BaO- and PbO-free X-ray opaque glasses having a refractive index n | 2011-09-08 |
20110218269 | DRY-COATED OXYGEN-SCAVENGING PARTICLES AND METHODS OF MAKING THEM - A method of dry coating oxidizable particles with activating particles. The method includes accreting at least portions of the activating particles onto surfaces of the oxidizable particles by mechanically induced juxtapositions to form composite particles; and abrading the composite particles to more evenly distribute the activating component over surfaces of the activating particles. | 2011-09-08 |
20110218270 | USE OF LINEAR TRIETHYLENTETRAMINE AS CURING AGENT FOR EPOXY RESINS - The present invention relates to an amine composition comprising linear triethylene-tetramine and one or more amine compounds selected from the group consisting of tertiary amines derived from the condensation of ethylenediamine and methyl-substituted compounds derived from linear triethylenetetramine as well as a method of production for said composition. | 2011-09-08 |
20110218271 | CREPING ADHESIVE MODIFIER AND PROCESS FOR PRODUCING PAPER PRODUCTS - The present invention relates to the use of a quaternary ammonium complex comprising at least one non-cyclic amide as a modifier for a creping adhesive used on a creping cylinder, e.g., a Yankee dryer. | 2011-09-08 |
20110218272 | THERMOSETTING RESIN COMPOSITION AND PREPREG USING THE SAME - Provided are a thermosetting resin composition suitable for forming a composite material that has excellent mechanical characteristics, such as wet heat resistance and toughness, and also a prepreg using the same. The thermosetting resin composition includes at least a component [A] including thermoplastic resin particles and a thermosetting resin [B]. The component [A] includes a melt blend of at least the components [A-1] and [A-2] given below. In the particles, the component [A-1] and the component [A-2] may be in a non-compatibilized state or a compatibilized state. | 2011-09-08 |
20110218273 | METAL STABILIZERS FOR EPOXY RESINS AND ADVANCEMENT PROCESS - A process comprising: contacting a) an epoxy resin; b) a compound selected from the group consisting of a phenol-containing compound, an isocyanate-containing compound, and mixtures thereof and c) a stabilizer comprising a metal-containing compound, said metal-containing compound comprising a metal selected from the Group 11-13 metals and combinations thereof; in the presence of a catalyst in an advancement reaction zone under advancement reaction conditions to produce an advancement reaction product is disclosed. | 2011-09-08 |
20110218274 | Bituminous Composition - A bituminous composition including, based on total weight of the bituminous composition, (a) hard bitumen in an amount of 0.5% to 7.5% by weight, the hard bitumen being characterized by a penetration number of 100 dmm or less at 25° C. as determined according to the American Association of State Highway and Transportation Officials (AASHTO) Method T49; (b) emulsifier in an amount of 0.0005% to 0.2% by weight, wherein the emulsifier has a Hildebrand solubility parameter of at least 19 (MPa) | 2011-09-08 |
20110218275 | TWO-COMPONENT SOLVENT-FREE POLYURETHANE ADHESIVES - A two-component solvent-free polyurethane laminating adhesive for flexible packaging, including a First Component and a Second Component is provided. The First Component, which acts as a resin, includes a first vegetable oil based Polyol A in an amount from 20 to 40 weight percent, a second vegetable oil based Polyol B in an amount from 0.5 to 5 weight percent, and a Polyisocyanate C in an amount from 60 to 74 weight percent. The Second Component, which acts as a hardener, includes a first vegetable oil based Polyol A in an amount from 87 to 99 weight percent, and a Polyol E in an amount from 0.5 to 5 weight percent. The first vegetable oil based Polyol A is preferably a hydroxylated castor oil, and the second vegetable oil based Polyol B is preferably hydroxylated linseed oil. | 2011-09-08 |
20110218276 | N-ALKOXYLATED 2,3-ANTHRAQUINONEDICARBOXIMIDES FOR POLYMER COLORATION, PREPARATION AND USE - The present invention relates to a compound of formula (I) | 2011-09-08 |
20110218277 | PRESSURIZED INK COMPOSITIONS AND A BALL POINT PEN COMPRISING THE SAME - A pressurized ball point pen ink composition comprising 30-65% of organic solvent, 15-50% of resin, 0.1-3% of viscosity imparting agent, 0.01 to 1% of polyvinyl pyrrolidone, 2 to 20% of lubricant, 5-25% of colorant; and 0.1-5% of amines and/or 0.1 to 20% diols or polyols; amines and/or diols or polyols capable of forming temporary bridging between silica particles at the same time forming associative coupling between amines itself and diols or polyol itself to obtain the ink composition having viscosity of about 10K to 45K cps. The pressurized ball point pen ink composition further comprising higher alcohol as anti-leakage and plasticizing additive in the ink composition to reduce the viscosity of the ink composition from 13K to 15K cps to below 1 0000 cps. The ink composition prevents leakage, bobbling and other defects associated with the prior art at the same time gives pleasure while writing. The pen comprising, the above ink compositions, which are manufactured by the process of the invention. | 2011-09-08 |
20110218278 | RESIN COMPOSITION AND MOLDED PRODUCT - A resin composition containing at least (A) a polylactic acid, (B) a phosphazene compound, and (C) a rubber and/or thermoplastic elastomer. | 2011-09-08 |
20110218279 | POLYOLEFIN RESIN COMPOSITION - The present invention provides a polyolefin-based resin composition containing a crystal nucleating agent having a specific structure, which polyolefin-based resin composition has a superior transparency and whose crystallization is facilitated. | 2011-09-08 |
20110218280 | SOLAR CELL SEALING FILM AND SOLAR CELL USING THE SEALING FILM - The object of the present invention to provide a solar cell sealing film comprising chiefly ethylene-vinyl acetate copolymer, organic peroxides for giving crosslinked structure, which suppresses occurrence of blister without reduction of crosslink rate, even if the film contains silane-coupling agents for improving adhesive strength. | 2011-09-08 |
20110218281 | METHOD FOR PREPARING THERMOPLASTIC ELASTOMER COMPOSITION - Provided is a thermoplastic elastomer composition, which includes a halogenated isoolefin/para-alkylstyrene copolymer rubber dispersed in a polyamide resin in order to improve the fatigue durability of a polyamide resin, while maintaining high flowability of the polyamide. A thermoplastic elastomer composition comprising a continuous phase composed of a modified polyamide resin (A) and a dispersed phase composed of a halogenated isoolefin/para-alkylstyrene copolymer rubber (B) is provided. The modified polyamide resin (A) is a resin obtained by melt-kneading 100 parts by weight of a polyamide resin (C) with not less than 0.05 part by weight and less than 3 parts by weight a compound (D), such as a monofunctional epoxy compound, capable of binding to a terminal amino group of the polyamide resin at a temperature not lower than the melting point of the polyamide resin (C). The composition can be used as an inner liner of a pneumatic tire. | 2011-09-08 |
20110218282 | INK COMPOSITION AND A BALL POINT PEN COMPRISING THE SAME - A ball point pen ink composition having viscosity of at least 500 cps at 25° C. comprising 5-25% of slow evaporating organic solvent, 20-55% fast evaporating solvent, 16 to 36% of resin, 0.1 to 2% of structural viscosity imparting agent, 0.05 to 1% of polyvinyl pyrrolidone, 0.1 to 25% of lubricant, 3-25% of colourant, and 0.01 to 3% of amines/polyamines and/or 0.1 to 20% diols or polyols as associative thickening agents/additives; amines and/or diols or polyols capable of forming temporary bridging between silica particles at the same time forming associative coupling between amines itself and diols or polyol itself to obtain the ink composition having ultra low viscosity of about at least 500 cps and yet preventing leakage. The ink composition prevents leakage, bobbling and other defects associated with the prior art and at the same time gives pleasure while writing. The pen comprising, the above ink, is manufactured by the process of the invention. | 2011-09-08 |
20110218283 | REACTOR THERMOPLASTIC POLYOLEFIN ELASTOMER COMPOSITION - A thermoplastic elastomer composition is disclosed comprising about 100 parts by weight of component (A) and about 20 to about 100 parts by weight of component (B). Component (A) is a polypropylene resin comprising about 60 to about 90% by weight of component (i) and about 40 to about 10% by weight of component (ii). Component (i) is a propylene homopolymer or copolymer of propylene and at least one monomer group consisting of ethylene and an α-olefin having 4 or more carbon atoms. Component (ii) is an ethylene-α-olefin copolymer comprising about 20 to about 50% by weight ethylene units. Component (B) is an ethylene-α-olefin elastomer comprising about 60 to about 85% by weight ethylene units and about 40 to about 15% by weight of α-olefin units. Component (B) has a Mooney stress relaxation area of from 180 to 300. | 2011-09-08 |
20110218284 | COMPOSITION COMPRISING A FLUORINE-CONTAINING ORGANOPOLYSILOXANE AND A PROCESS FOR PREPARING THE SAME - Present invention provides a fluorine-containing organopolysiloxane composition comprising a fluorine-containing silicone polymer having a three-dimensional, cross-linked structure, prepared by addition polymerizing the following (A), (B) and (C) and containing 10 to 30 mass % of the fluorine atoms, relative to a total mass of (A) to (C),
| 2011-09-08 |
20110218285 | LOW VOC ADDITIVES FOR EXTENDING THE WET EDGE AND OPEN TIME OF AQUEOUS COATINGS - Disclosed is a low VOC coating additive employing a water-dispersible polymer, a water insoluble plasticizer, cyclohexanedimethanol, and optionally an amphiphilic component. The additive can be added to a coating to improve at least one performance characteristics of the coating, such as, wet-edge time, open time, scrub resistance, wet adhesion, and water resistance. | 2011-09-08 |
20110218286 | MOLYBDENUM COMPRISING NANOMATERIALS AND RELATED NANOTECHNOLOGY - Nanoparticles comprising molybdenum, methods of manufacturing nanoparticles comprising molybdenum, and nanotechnology applications of nanoparticles comprising molybdenum, such as electronics, optical devices, photonics, reagents for fine chemical synthesis, pigments and catalysts, are provided. | 2011-09-08 |
20110218287 | Coatings for electronic circuits - Printed circuit boards are coated with nanoparticulate inorganic oxides. The coatings have increased partial discharge resistance. | 2011-09-08 |
20110218288 | CARBON FIBER AGGREGATES AND PROCESS FOR PRODUCTION OF SAME - A method of producing a carbon fiber aggregate, including bringing a supported catalyst into contact with a carbon-containing compound in a heated zone, the supported catalyst being prepared by heat-treating aluminum hydroxide which has a BET specific surface area of 1 m | 2011-09-08 |
20110218289 | MIXTURE COMPOSITION CONTAINING COPOLYMERS BASED ON UNSATURATED CARBOXYLIC ACID AND ALKENYL ETHER DERIVATIVES AND COPOLYMERS AND TERPOLYMERS CONTAINING SULFO GROUPS AND USE THEREOF - The invention relates to a mixture composition having dispersing properties, containing copolymers based on unsaturated mono or dicarboxylic acid derivatives and oxyalkylene ethers as component I and water-soluble copolymers and terpolymers containing sulfo groups having an average molecular weight of 50 000-20 000 000 g/mol as component II. By combining both components, which can be respectively characterized by four different structural units, it is possible to obtain mixture compositions which can, more particularly, be used as dispersing agents for organic and/or inorganic pigments and fillers, in addition to known applications in the field of structural chemistry. In the field of structural chemistry, the mixture compositions are suitable for use on account of the dispersing properties thereof, particularly in ceramic systems and in water-based painting and coating systems. Independently of the dispersing effect thereof, the described mixture compositions are also excellent solvents, wherein they can be used more particularly as casein substitutes, even in self-leveling gap-filling materials and troweling compounds by virtue of the stabilizing effect thereof. The inventive mixture composition combines known positive properties of components I and II and can be used in new fields of application, even in the non-structural chemistry field. | 2011-09-08 |
20110218290 | ZWITTERIONIC/AMPHIPHILIC PENTABLOCK COPOLYMERS AND COATINGS THEREFROM - A zwitterionic/amphiphilic pentablock copolymer was prepared using atom transfer radical polymerization (ATRP). The pentablock copolymer is prepared for the atom transfer radical polymerization of a PDMS-PEO-Br macroinitiator and SBMA. The pentablock copolymer is incorporated into a polyurethane coating composition which is useful for antifouling and/or fouling release applications. | 2011-09-08 |
20110218291 | PROCESS FOR PREPARING AQUEOUS DISPERSIONS - The present invention relates to a process for preparing aqueous dispersions. The invention also relates to the formation of core-shell particles in aqueous dispersions. The core-shell particles are useful as impact-modifiers for poly(meth)acrylate moulding compositions. | 2011-09-08 |
20110218292 | MONOVINYL AROMATIC POLYMER COMPOSITIONS WITH A NOVEL COMBINATION OF STIFFNESS AND STRESS CRACK RESISTANCE - A rubber modified polystyrene composition that includes the reaction product formed by polymerizing a monomer mixture containing at least 75 weight percent of one or more monovinylaromatic monomers in the presence of rubber particles to form a dispersion of rubber particles in a vinyl aromatic polymer. The dispersed rubber particles have an average particle diameter of from about 6 to about 10 microns. The composition has a gel content of from about 28% to about 36% by weigh. The composition has a swell index of less than 13 and contains no more than 2 wt. % of plasticizers. The present composition can be used as a refrigerator liner material. The liner material can be down gauged while maintaining desirable performance characteristics. | 2011-09-08 |
20110218293 | NOVEL PROPYLENE POLYMER COMPOSITIONS - The invention relates to propylene polymer compositions comprising 50-70 wt % of a propylene homo- or copolymer, 5-20 wt % of a first elastomeric ethylene-propylene copolymer, 5-25 wt % of a second elastomeric ethylene-propylene copolymer and 5-30 wt % of an ethylene polymer. The propylene polymer compositions are suitable for moulding and they have low haze and a good impact strength/stiffness balance with good impact strengths at low temperatures. | 2011-09-08 |
20110218294 | BLENDS OF POLYARYLENE ETHERS AND POLYARYLENE SULFIDES - The present invention relates to thermoplastic molding compositions comprising the following components:
| 2011-09-08 |
20110218295 | ANIONIC ASSOCIATIVE RHEOLOGY MODIFIERS - The present invention relates to new anionic associative rheology modifiers, their manufacture and application. | 2011-09-08 |
20110218296 | ANIONIC ASSOCIATIVE RHEOLOGY MODIFIERS - The present invention relates to new anionic associative rheology modifiers, their manufacture and application. | 2011-09-08 |
20110218297 | NOVEL GLUCONACETOBACTER STRAIN HAVING CELLULOSE PRODUCING ACTIVITY - Disclosed herein is a novel | 2011-09-08 |
20110218298 | METHOD FOR THE PREPARATION OF POLY (DISULFIDE) POLYMERS AND GELS - High molecular weight disulfide polymers are synthesized in aqueous media by exposing dithiol compounds to a mild oxidizing environment in the presence of a tertiary amine catalyst. The unique oxidizing system polymerizes monomers through the formation of sulfur-sulfur bonds between dithiol compounds. The same oxidizing system may be used to make disulfide-crosslinked gels from compounds containing multiple thiol groups. The oxidizing system is comprised of oxygen at atmospheric concentration and dilute hydrogen peroxide. A filler such as carbon black may be incorporated into the polymer or cross-linked gel during polymerization. A polydisulfide polymer is provided having a weight average molecular weight of greater than about 100,000 g/mol and a polydispersity index of about 2 or less. A tetrathiol composition results from a reaction of a diacrylate with a trithiol. The tetrathiol composition may be subjected to an oxidizing environment with a tertiary amine catalyst to provide a polytetrathiol polymer network. | 2011-09-08 |
20110218299 | UNIVERSAL PRIMER COMPOSITIONS AND METHODS - A composition for and method for bonding a substrate. In general, applied to a substrate will be a primer composition that includes an adhesion promoter, which is an adduct prepared by the reaction of at least one aromatic polyisocyanate compound, with an active hydrogen containing moiety of an organofunctional silane, and a prepolymer derived from the reaction of at least one aliphatic polyisocyanate and a polyol, and is at least partially reacted with an active hydrogen containing moiety of an organofunctional silane. | 2011-09-08 |
20110218300 | PROCESS TO REMOVE SILANOL FROM THE PREPARATION OF A MODIFIED POLYMER - The invention provides a method for a preparation of a polymer selected from the following: (a) modified interpolymer comprising, in polymerized form, a conjugated diene and an aromatic alpha-olefin, or (b) a modified polymer comprising, in polymerized form, a conjugated diene; and wherein said method comprising at least the following steps: polymerizing monomers comprising at least one conjugated diene monomer in at least one polymerization reactor, in the presence of at least one solvent, to form the polymer, optionally coupling a fraction of the polymer chains using at least one coupling agent, modifying the polymer with at least one modifying agent, in at least one reactor, in the presence of the at least one solvent, to form a modified polymer solution; optionally, contacting the modified polymer solution with at least one proton donating compound; contacting the modified polymer solution with water; removing the at least one solvent; contacting the removed solvent with at least one material that will react with, and/or absorb, silanol to form a purified solvent, recirculating the purified solvent back to the at least one polymerization reactor or to a storage container. | 2011-09-08 |
20110218301 | POLYMER AND METHOD FOR PRODUCING THE SAME - A method for producing a polymer, including polymerizing a ring-opening polymerizable monomer in a compressive fluid with a metal-free organic catalyst to produce a polymer. | 2011-09-08 |
20110218302 | PROCESS FOR PRODUCTION OF POLYMERS HAVING FUNCTIONAL GROUPS, AND STAR POLYMERS OBTAINED THEREBY - It is to provide a method for producing a polymer by a living anionic polymerization, wherein the number of functional groups and the introduction position are accurately specified in the polymer. For this purpose, a cinnamyl alcohol represented by the following formula [I] or a derivative thereof is subjected to a reaction when conducting a living anionic polymerization. In formula [I], R | 2011-09-08 |
20110218303 | THERMOPLASTIC POLYMER COMPOSITION AND SHEET-LIKE MOLDED ARTICLE THEREFROM - [Object] Provided are a sheet-like molded article having excellent surface smoothness, moldability, flexibility, and a high transmittance of short-wavelength light, and a thermoplastic polymer composition used to produce the sheet-like molded article. | 2011-09-08 |
20110218304 | LOW COST AND HIGH YIELD METHOD OF MAKING LARGE QUANTITY AND HOMOGENOUS METAL NANOPARTICLES AND CONTROLLING THEIR SOLUBILITY - The present invention is directed to a low cost and high yield synthetic method of producing large quantity and homogenous metal nanoparticles, which are capped by both hydrophilic and hydrophobic surfactants and soluble in water, water-miscible solvents, and non-polar solvents. The solubility of metal nanoparticles in different solvents can be controlled by simply changing the ratio of hydrophilic and hydrophobic surfactants. | 2011-09-08 |
20110218305 | AZIDE-CONTAINING FLUOROPOLYMERS AND THEIR PREPARATION - Fluoropolymers containing one or more azide group wherein the azide group is not a sulfonyl-azide group and processes of preparing them. | 2011-09-08 |
20110218306 | ATOM TRANSFER RADICAL POLYMERIZATION PROCESS - Embodiments of the polymerization process of the present invention are directed to polymerizing free radically polymerizable monomers in the presence of a polymerization medium initially comprising at least one transition metal catalyst and an atom transfer radical polymerization initiator. The polymerization medium may additionally comprise a reducing agent. The reducing agent may be added initially or during the polymerization process in a continuous or intermittent manner. The polymerization process may further comprises reacting the reducing agent with at least one of the transition metal catalyst in an oxidized state and a compound comprising a radically transferable atom or group to form a compound that does not participate significantly in control of the polymerization process. Embodiments of the present invention comprise reacting a reducing agent with at least one of catalyst in an oxidized state and a compound comprising a radically transferable atom or group to initiate and/or maintain catalytic activity throughout the polymerization process. | 2011-09-08 |
20110218307 | Systems and Methods for Fabricating Polymers - The present invention is broadly directed to various methods and systems for gas and liquid phase polymer production. In certain embodiments, the methods are performed in conjunction with a polymerization reactor system such as gas phase reactor system or liquid phase reactor system. The invention is also broadly directed to various systems in which polymer properties are manipulated by addition of DEALE directly to a polymerization reactor system. | 2011-09-08 |
20110218308 | ETHYLENE -a-OLEFIN COPOLYMER AND MOLDED OBJECT THEREOF - The purpose of the invention is to provide an ethylene-α-olefin copolymer, which has a high melt tension but a small neck-in, and a molded object produced by extrusion molding of the copolymer. An ethylene-α-olefin copolymer having a monomer unit based on ethylene and a monomer unit based on an α-olefin having 3 to 20 carbon atoms, which has a melt flow rate (MFR) of 0.1 to 100 g/10 min, a density (d) of 850 to 940 kg/m | 2011-09-08 |
20110218309 | Preparation of ultra high molecular mass polyethylene and ultra high molecular mass polyethylene having improved crosslink ability prepared thereb - The invention pertains to a method for the preparation of ultra high molecular mass polyethylene by polymerization in suspension or in gas phase in the presence of a chromium catalyst sitting on an alumosilicate support material. The chromium catalyst has been subjected to a fluorinating treatment and the polymerization is performed under low temperature conditions within a temperature range of from 50 to 100° C. The invention pertains also to ultra high molecular mass polyethylene prepared by that method and having a density in the range of from 0.930 to 0.950 g/cm | 2011-09-08 |
20110218310 | PROCESS FOR THE PREPARATION OF AN UNSUPPORTED, SOLID OLEFIN POLYMERISATION CATALYST AND USE IN POLYMERISATION OF OLEFINS - Improved process for the preparation of an unsupported, heterogeneous olefin polymerisation catalyst, comprising an organometallic compound of a transition metal of Group 3 to 10 of the Periodic Table (IUPAC) or of an actinide or lanthanide in the form of solid particles comprising the steps of a) preparing a solution of an aluminoxane and an ionic complex M-X, M being an alkali or earth alkali metal and X being a halide or pseudo halide, in a molar ratio of Al of the aluminoxane to M of the ionic complex between 80:1 and 300:1, b) mixing said solution with an organometallic compound of a transition metal of Group 3 to 10 of the Periodic Table (IUPAC) or of an actinide or lanthanide in a molar ratio of M of the ionic complex to the transition metal of the organometallic compound between 1:1 and 4:1, yielding a second solution, c) dispersing said second solution obtained in step b) in a solvent immiscible therewith to form an emulsion in which said second solution of step b) forms the dispersed phase in the form of droplets and the solvent immiscible with said solution forms the continuous phase, d) solidifying said dispersed phase to convert said droplets to solid particles and optionally recovering aid particles to obtain said catalyst, the catalysts itself and its use for olefin polymerisation. | 2011-09-08 |
20110218311 | Melt-processible Poly(tetrafluoroethylene) - Melt-processible, thermoplastic poly(tetrafluoroethylene) (PTFE) compositions are disclosed and methods for making and processing same. Additionally, products comprising these compositions are described. | 2011-09-08 |
20110218312 | METHOD FOR PRODUCING N-ISOPROPYL(METH)ACRYLAMIDE - A novel process is described which allows N-isopropyl(meth)acrylamide to be obtained in high purity and yield in a simple manner, by reacting methacrylic anhydride with isopropylamine, optionally in a solvent. | 2011-09-08 |
20110218313 | POLYMER PARTICLE AND METHOD FOR PRODUCING THE SAME - A method for producing polymer particles, including (A) polymerizing and granulating a ring-opening polymerizable monomer in a compressive fluid with a catalyst in the presence of a surfactant, or (B) polymerizing and granulating an addition polymerizable monomer in a compressive fluid in the presence of a silicone surfactant. | 2011-09-08 |
20110218314 | CONTINUOUS OLIGOMERIZATION OF ISOCYANATES - A process for oligomerizing isocyanates includes a step of continuous conversion of an isocyanate monomer into polyisocyanate containing carbamate and/or allophanate groups, in the presence of a catalyst, wherein the conversion step is carried out in a reactor having a specific heat exchange coefficient of greater than or equal to approximately 200 kW/m | 2011-09-08 |
20110218315 | PROCESS FOR PREPARING A POLYETHER ETHER KETONE - A process for preparing a polyether ether ketone. Sodium carbonate is used alone as the condensation agent, and 4,4′-difluorodibenzophenone, p-benzenediol and biphenyldiol are subjected to polymerizing. After the corresponding prepolymer is obtained, the reaction temperature is elevated and p-benzenediol is further added as a chain extender to react for a period of time to produce high-viscosity polyether ether ketone. | 2011-09-08 |
20110218316 | POLYESTER FILMS WITH IMPROVED OIL REPELLENCY - Provided are films made from copolyesters having improved oil repellency as compared to conventional copolyesters. The copolyesters are derived from certain perfluorinated monomers. | 2011-09-08 |